Results 81 to 90 of about 29,304 (119)

Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple Sclerosis. [PDF]

Clin Pharmacokinet
Serkland TT, Oma AF, Hallin EI, Øverås MH, Nygaard GO, Myhr KM, Torkildsen Ø, Röblitz S, Skrede S.   +8 more
europepmc   +1 more source

Central Vein Sign and Paramagnetic Rim Lesions in Patients with Relapsing-Remitting Multiple Sclerosis: An Assessment of Prevalence and Anatomical Location. [PDF]

Neurol Int
Jansone MN, Zdanovskis N, Polunosika E, Pastare D, Karelis G.   +4 more
europepmc   +1 more source

Serum amylin levels in patients with multiple sclerosis: A cross-sectional case-control study. [PDF]

Medicine (Baltimore)
Cinkir U, Bir LS, Tekin S, Karagulmez AM, Avci Cicek E, Senol H.   +5 more
europepmc   +1 more source

Longitudinal changes of serum immunoglobulins under ocrelizumab: factors associated with hypogammaglobulinemia and infection risk in a real-world multiple sclerosis cohort. [PDF]

Neurol Res Pract
Bohn A, Teubner FS, Tauber SC, Waschbisch A.   +3 more
europepmc   +1 more source

Two Cases of Multiple Sclerosis in a Family With X-Linked Charcot-Marie-Tooth Disease. [PDF]

Neurol Genet
Menih M, Hojs Fabjan T, Maver A, Peterlin B.   +3 more
europepmc   +1 more source

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis. [PDF]

J Med Cases
Ruggiero A, Redemagni C, Camnasio CA, Morteo V, Carcagni F, Zatti S, Strada I, Roccio M, Rigoni E, Cassani C, Colombo E.   +10 more
europepmc   +1 more source

Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis. [PDF]

Front Immunol
Buhelt S, Hansen MB, Søndergaard HB, El Mahdaoui S, Hansen MM, Mahler MR, Romme Christensen J, Sellebjerg F.   +7 more
europepmc   +1 more source

Plasma-Derived Extracellular Vesicle microRNAs in Multiple Sclerosis: An Exploratory Case-Control Study on Phenotypic Discrimination. [PDF]

Int J Mol Sci
Vrînceanu O, Manu D, Maier S, Bănescu C, Carstea AC, Bălașa R.   +5 more
europepmc   +1 more source

Machine learning methods evaluation for identification of cognitive phenotypes in multiple sclerosis and their MRI correlates. [PDF]

Front Neurosci
Romaniszyn-Kania P, Galus W, Wyszomirska J, Zawiślak-Fornagiel K, Bożek O, Ledwoń D, Kania D, Tuszy A, Siuda J, Mitas AW.   +9 more
europepmc   +1 more source

Multi-shot diffusion tensor imaging in the lumbosacral spinal cord: Characterizing heterogeneity in healthy tissue and differences in multiple sclerosis. [PDF]

Imaging Neurosci (Camb)
Cronin AE, Zhang X, Combes A, Vandekar S, Dunay GL, Narisetti L, Sweeney G, Prock L, Houston D, Salakhov A, Schilling KG, Stubblefield S, McKnight CD, Bagnato F, Sriram S, Smith SA, O'Grady KP.   +16 more
europepmc   +1 more source